Donald J. Hayden Jr., Director at Vitae Pharmaceuticals, Inc (VTAE), sold 32,260 shares at $7.42 ($239K) on 2016-03-21, disclosed to the SEC on 2016-03-21.
Open-market sale of $239k VTAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.42 | 16,130 | $120K | 50.0% |
| 2 | $7.42 | 16,130 | $120K | 50.0% |
| Total | $7.42 avg | 32,260 | $239K | 100% |
| Filing → |
| RGNX | SELL | 2020-02-07 | $100K | — | Filing → |
| RGNX | SELL | 2020-01-21 | $160K | — | Filing → |
| RGNX | SELL | 2020-01-16 | $1.4M | — | Filing → |